Edition:
United States

IRadimed Corp (IRMD.OQ)

IRMD.OQ on NASDAQ Stock Exchange Capital Market

8.40USD
29 Mar 2017
Change (% chg)

$0.10 (+1.20%)
Prev Close
$8.30
Open
$8.35
Day's High
$8.60
Day's Low
$8.25
Volume
6,553
Avg. Vol
16,316
52-wk High
$22.49
52-wk Low
$7.85

Latest Key Developments (Source: Significant Developments)

Iradimed Corp Q4 non-GAAP EPS $0.11
Monday, 6 Feb 2017 07:00am EST 

Iradimed Corp : Iradimed Corporation announces fourth quarter 2016 financial results . Q4 non-gaap earnings per share $0.11 . Q4 gaap earnings per share $0.10 . Q4 revenue $6.0 million versus $8.8 million . Sees q1 2017 non-gaap earnings per share $0.00 to $0.01 . Sees fy 2017 non-gaap earnings per share $0.14 to $0.18 . Sees q1 2017 gaap loss per share $0.01 to $0.02 . Sees fy 2017 gaap earnings per share $0.07 to $0.08 . Sees q1 2017 revenue $5.2 million to $5.3 million . Sees fy 2017 revenue $23.9 million to $24.3 million . Iradimed Corp - at december 31, 2016, company had approximately $1.6 million of backlog . Iradimed Corp - at december 31, 2016, company had approximately $1.6 million of backlog and expects that backlog will approximate this level throughout 2017 . Iradimed Corp - company expects that approximately $0.3 million of its q1 2017 revenue will come from backlog .Fy2017 earnings per share view $0.16, revenue view $24.0 million -- Thomson Reuters I/B/E/S.  Full Article

Iradimed Corp reports 2017 annual and Q1 financial guidance
Wednesday, 18 Jan 2017 07:00am EST 

Iradimed Corp : Iradimed Corporation announces 2017 annual and first quarter financial guidance . Sees Q1 2017 non-GAAP earnings per share $0.00 to $0.01 . Sees FY 2017 non-GAAP earnings per share $0.14 to $0.18 . Sees Q1 2017 GAAP loss per share $0.01 to $0.02 . Sees FY 2017 GAAP earnings per share $0.07 to $0.08 . Sees Q1 2017 revenue $5.2 million to $5.3 million . Sees FY 2017 revenue $23.9 million to $24.3 million . Sees FY 2016 revenue about $32.6 million .Iradimed Corp says at December 31, 2016, company had approximately $1.4 million of backlog remaining.  Full Article

Iradimed Q2 adjusted earnings per share $0.24
Friday, 29 Jul 2016 07:00am EDT 

Iradimed Corp : Full year revenue guidance was unchanged at $39.0 million to $40.0 million . Iradimed corporation announces second quarter 2016 financial results . Sees q3 2016 non-gaap earnings per share $0.23 to $0.24 . Q2 non-gaap earnings per share $0.24 . Q2 gaap earnings per share $0.19 . Sees q3 2016 revenue about $9.9 million to $10 million . Q2 revenue rose 29.7 percent to $9.9 million . Increased its full year 2016 non-gaap earnings guidance and now expects non-gaap diluted earnings per share of $0.91 to $0.93 for 2016 .Fy2016 earnings per share view $0.89, revenue view $39.2 million -- Thomson Reuters I/B/E/S.  Full Article

Iradimed Corp appoints Roger Susi as chairman of the board
Tuesday, 14 Jun 2016 04:00pm EDT 

Iradimed Corp : Iradimed Corporation announces election of Roger Susi as chairman of the board .Susi's appointment is result of resignation of Jim Hawkins from board.  Full Article

Iradimed Corp gives FY, Q1 2016 guidance; raises Q4 2015 revenue guidance
Monday, 11 Jan 2016 07:30am EST 

Iradimed Corp:Expects FY 2016 revenue of $39.0 million to $40.0 million and non-GAAP diluted earnings per share of $0.83 to $0.85.Expects Q1 2016 revenue of $9.0 million to $9.1 million and non-GAAP diluted earnings per share of $0.17 to $0.18.Expects to report revenue of about $8.8 million for Q4 2015, exceeding the company's guidance of $8.5 million to $8.6 million.  Full Article

Iradimed Corp announces pricing of secondary offering of common stock
Friday, 18 Dec 2015 08:30am EST 

Iradimed Corp:Announced the pricing of an underwritten secondary offering of 1,043,479 shares of its common stock by Roger Susi.Shares will be offered at a price of $24.25 per share.  Full Article

Iradimed Corp announces dismissal of appeal
Friday, 30 Oct 2015 07:30am EDT 

Iradimed Corp:Says regards to the Lam Civil Action matter, U.S. Court of Appeals for the Eleventh Circuit, on joint motion of parties, dismissed with prejudice the plaintiff's appeal from May 26, 2015 dismissal of all claims by U.S. District Court for Southern District of Florida.  Full Article

Iradimed Corp gives Q4 2015 guidance above estimates; raises FY 2015 guidance
Friday, 30 Oct 2015 07:30am EDT 

Iradimed Corp:Expects Q4 2015 revenue of about $8.5-$8.6 mln and non-GAAP diluted EPS of $0.19-$0.20.Raises FY 2015 revenue guidance and expects to report revenue of $31.3 million to $31.4 million.Raises FY 2015 non-GAAP diluted EPS guidance to $0.68-$0.69, an increase from the previous guidance of $0.63 to $0.65.Q4 2015 revenue of $7.9 mln and EPS of $0.17 - Thomson Reuters I/B/E/S.FY 2015 revenue of $30.2 mln and EPS of $0.63 - Thomson Reuters I/B/E/S.  Full Article

Iradimed Corp gives Q3 2015 guidance above analysts estimates; raises FY 2015 guidance
Thursday, 30 Jul 2015 07:30am EDT 

Iradimed Corp:Expects Q3 2015 revenue of about $7.7-$7.8 million and non-GAAP diluted EPS of $0.16-$0.17.Raises FY 2015 guidance.Expects FY 2015 $30.2-$30.4 million, an increase from the previous guidance of $29.0-$30.0 million.Expects FY 2015 non-GAAP diluted EPS guidance in the range of $0.63-$0.65, an increase from the previous guidance of $0.57-$0.59.Q3 2015 revenue of $7.40 million and EPS of $0.13 - Thomson Reuters I/B/E/S.FY 2015 revenue of $29.40 and EPS of $0.50 - Thomson Reuters I/B/E/S.  Full Article

Iradimed Corp gives Q2 2015 guidance; raises FY 2015 guidance
Thursday, 30 Apr 2015 07:00am EDT 

Iradimed Corp:Sees Q2 2015 revenue of $7.1 million to $7.2 million.Sees Q2 2015 non-GAAP diluted EPS of $0.14 to $0.15.The company increased FY 2015 revenue guidance and now expects to report revenue of $29.0 million to $30.0 million.Increases FY 2015 non-GAAP diluted earnings per share guidance and now expects non-GAAP diluted earnings per share of $0.57 to $0.59.  Full Article

More From Around the Web

BRIEF-Iradimed Corp Q4 non-GAAP EPS $0.11

* Iradimed Corporation announces fourth quarter 2016 financial results